Tumour cell expression of interleukin 6 receptor α is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

The Journal of Pathology: Clinical Research

  ^{1    2    2    3    4    5} 

[1] Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway;Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway;Department of Oncology, Haukeland University Hospital, Bergen, Norway;Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway;Department of Pathology, Haukeland University Hospital, Bergen, Norway;Department of Pathology, Haukeland University Hospital, Bergen, Norway;Department of Urology, Haukeland University Hospital, Bergen, Norway;Department of Clinical Medicine, University of Bergen, Bergen, Norway;

关键词: clear cell renal cell carcinoma;    sunitinib;    interleukin 6;    interleukin 6 receptor α;    response rates;    biomarker;    anti‐angiogenesis;    inflammation;    immunohistochemistry;    treatment efficacy;   

DOI  :  10.1002/cjp2.96

来源: publisher

【 授权许可】

Unknown